000 | 00957 a2200289 4500 | ||
---|---|---|---|
005 | 20250512121658.0 | ||
264 | 0 | _c19730301 | |
008 | 197303s 0 0 eng d | ||
022 | _a0003-0465 | ||
024 | 7 |
_a10.1016/s0003-0465(16)32460-0 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWeaver, W E | |
245 | 0 | 0 |
_aProtecting our professional prerogatives. _h[electronic resource] |
260 |
_bJournal of the American Pharmaceutical Association _cJan 1973 |
||
300 |
_a30-1 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aDrug Labeling |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aLegislation, Drug |
650 | 0 | 4 | _aMethadone |
650 | 0 | 4 | _aMethotrexate |
650 | 0 | 4 | _aPharmacists |
650 | 0 | 4 | _aPharmacy |
650 | 0 | 4 | _aUnited States |
773 | 0 |
_tJournal of the American Pharmaceutical Association _gvol. 13 _gno. 1 _gp. 30-1 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0003-0465(16)32460-0 _zAvailable from publisher's website |
999 |
_c4686254 _d4686254 |